Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel, Cisplatin, and Radiation with Filgrastim for Recurrent Head and Neck or Lung Cancer
NCT00021333Phase 2Completed
- Sponsor
- Fox Chase Cancer Center
- Start
- Sep 1999
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, cisplatin in head and neck cancer (HNC), lung cancer, sponsored by Fox Chase Cancer Center. Started Sep 1999; status: completed.
02
Drugs
paclitaxelcisplatin
03
Conditions
head and neck cancer (HNC)lung cancer
Beyond the preview
Go deeper on NCT00021333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00021333.